YHLO





NEWS：

YHLO's National-level Key Project Officially Launched

 2023-12-18

Breaking news! YHLO received FDA 510(k) clearance

 2023-12-13

BSI visited YHLO Shenzhen office, promoting further cooperation

 2023-10-25

Nobel Prize Winner Professor Arieh Warshe visited YHLO

 2023-09-19

YHLO R&D Center Japan officially settled

 2023-07-18





About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575). As a national high-tech enterprise with many intellectual properties, YHLO’s mission is to "Focus on Healthcare, Better Life with Technology".

Diagnostic for Human Health

Milestone

Corporate Values

Contact Us

MORE+

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +